Google unveils new wristband to collect trial participant data

By Zachary Brennan

- Last updated on GMT

Google unveils new wristband to collect trial participant data

Related tags Clinical trial Pharmaceutical industry Epidemiology

Google’s life sciences group is developing a wristband dedicated exclusively to tracking clinical trial participants’ vital signs and other data.

And unlike the consumer devices and apps from Apple, Fitbit and others, Google is looking to test its device’s accuracy in trials beginning this summer.

The preliminary testing of the device will be an important step in getting it into the hands of patients and companies running trials as current consumer wearables don’t yet offer the type of quality data that’s necessary for a trial.

At this point consumer wearables don’t give you medical or diagnostic-quality data, so none of them are close to being used for primary endpoints​,” Mark Shapiro, VP of clinical development at CRO Clinipace, explained to And “until you start collecting this data, perhaps as a pilot test, in some clinical trials, you’re not really going to know its potential value​,” he added.

There are also still questions around the data analysis of what is collected. 

Today, longitudinal data analysis in clinical trials is concerned with a specific test at ten or twelve time points​,” Shapiro said. “When you have continuous heart rate data for twelve weeks, we as an industry, will need to start thinking about more complicated pattern analysis. I think there is some trepidation that if you collect the data, you are obligated to search it for signals. Right now it isn’t clear how exactly to do that. In fact, this is an area I expect we’ll see industry asking for more guidance from regulatory authorities in the near future​.”

In terms of what types of trials wearables will be most useful for, Shapiro said he thinks that “with the current feature set, sleep tracking, heart rate tracking, even oxygen saturation, are amenable for trials in insomnia and perhaps outpatient cardiovascular trials.  They may be generally useful for monitoring cardiovascular safety of drugs in other therapeutic areas as well​.”

The search engine company plans to work with academic researchers and other unnamed drugmakers to test the device and seek regulatory clearance for its use in the US and Europe, Andy Conrad, head of the life sciences team at Google, told Bloomberg News​. Google may also look for a manufacturing partner, Conrad said.


In addition to pulse, heart rhythm and skin temperature, the experimental wristband can record environmental information like light exposure and noise levels.

Google has been relatively active in the wearable space recently, as the Internet giant previously partnered with Biogen Idec​ on a multiple sclerosis project tracking patients’ disease progression. The company also partnered with Novartis to develop a contact lens that can monitor glucose.

Novartis, meanwhile, forged an alliance with Qualcomm​ to collect chronic lung disease patients’ data via smart phones and a cloud-based platform.

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Related suppliers

Follow us


View more